关于公司
Our Xenium in situ analysis technology allows you to visualize and map genes at high sensitivity and subcellular resolution in situ. 10x Genomics is investing in development of the future in situ analysis technology by combining the strengths of Cartana and ReadCoor technologies.
US
未知
未验证公司
业务透明度
- 未验证公司信息
- 向他们的客户询问评论
- 没有回复负面评论